Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Korea University

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Private

Established: 1905-01-01

Employees: -

Market Cap: -

Website: http://www.korea.ac.kr

Clinical Trials

Korean Health Screening-Based Metabolic Dysfunction-Associated Steatotic Liver Disease Registry

Not yet recruiting

Conditions: Metabolic Dysfunction-Associated Steatotic Liver Disease
Cardiovascular Diseases

First Posted Date: 2025-02-25

Last Posted Date: 2025-02-27

Lead Sponsor: Korea University

Target Recruit Count: 6000

Registration Number: NCT06843421

Locations: 🇰🇷
Chung-Ang University Gwangmyeong Hospital, Gyeonggi-do, Gwangmyeong-si, Korea, Republic of
🇰🇷
Yonsei University Yongin Severance Hospital, Yongin, Gyeonggi-do, Korea, Republic of
🇰🇷
Inje Univerisity Sanggye Paik Hospital, Seoul, Nowon-gu, Korea, Republic of

and more 2 locations

Improving Executive Function in Korean Children With Autism

Not Applicable

Recruiting

Conditions: Autism Spectrum Disorder

Interventions: Behavioral: Parent Psychoeducation

First Posted Date: 2024-07-26

Last Posted Date: 2024-10-09

Lead Sponsor: Korea University

Target Recruit Count: 40

Registration Number: NCT06523660

Locations: 🇰🇷
Korea University, Seoul, Korea, Republic of

Combining Biomarkers (AFP, AFP-L3, and PIVKA-II) and Image Tools for Early Detection of Hepatocellular Carcinoma

Not Applicable

Recruiting

Conditions: Surveillance
Hepatocellular Carcinoma
Liver Cirrhosis

Interventions: Diagnostic Test: AFP-L3
Diagnostic Test: AFP
Diagnostic Test: PIVKA-II
Diagnostic Test: Sonography
Diagnostic Test: CT

First Posted Date: 2020-06-04

Last Posted Date: 2020-06-04

Lead Sponsor: Korea University

Target Recruit Count: 1418

Registration Number: NCT04414956

Locations: 🇰🇷
Korea University Ansan Hospital, Ansan, Gyeonggi-do, Korea, Republic of
🇰🇷
The Catholic University of Korea Uijeongbu St.Mary's Hospital, Uijeongbu, Gyeonggi-do, Korea, Republic of
🇰🇷
Keimyung University Dongsan Medical Center, Daegu, Korea, Republic of

and more 12 locations

Maintaining Antiviral Efficacy After Switching to Generic Entecavir 1 mg for Chronic Hepatitis B

Phase 4

Conditions: Chronic Hepatitis B

Interventions: Drug: Switching to Generic Entecavir (Baracle®)

First Posted Date: 2019-08-28

Last Posted Date: 2020-02-17

Lead Sponsor: Korea University

Target Recruit Count: 40

Registration Number: NCT04069858

Locations: 🇰🇷
Korea University Ansan Hospital, Ansan, Gyeonggi-do, Korea, Republic of

Tenofovir Combination or Mono-therapy for MDR CHB

Conditions: Chronic Hepatitis b With Multidrug Resistance

First Posted Date: 2018-07-24

Last Posted Date: 2018-07-24

Lead Sponsor: Korea University

Target Recruit Count: 236

Registration Number: NCT03597633

Locations: 🇰🇷
Korea University Ansan Hospital, Ansan, Gyeonggi-do, Korea, Republic of

Sorafenib Monotherapy vs. TACE-sorafenib Sequential Therapy for HCC With Metastasis

Phase 4

Conditions: Metastasis
Hepatocellular Carcinoma

Interventions: Procedure: transarterial chemoembolization (TACE)
Drug: Sorafenib

First Posted Date: 2018-05-08

Last Posted Date: 2018-05-08

Lead Sponsor: Korea University

Target Recruit Count: 130

Registration Number: NCT03518502

Locations: 🇰🇷
Korea University Ansan Hospital, Ansan, Gyeonggi-do, Korea, Republic of
🇰🇷
Soonchunghyang University Bucheon Hospital, Bucheon, Gyeonggi-do, Korea, Republic of
🇰🇷
Keimyung University Dongsan Hospital, Daegu, Korea, Republic of

and more 3 locations

Clinical Trial of Ingenol Mebutate Gel 0.015% & 0.05% in Actinic Keratosis

Phase 4

Completed

Conditions: Actinic Keratosis

Interventions: Drug: ingenol mebutate gel 0.05%
Drug: ingenol mebutate gel 0.015%

First Posted Date: 2016-03-23

Last Posted Date: 2018-04-18

Lead Sponsor: Korea University

Target Recruit Count: 77

Registration Number: NCT02716714

Locations: 🇰🇷
Korea University Ansan Hospital, Ansan-si, Gyeonggi-do, Korea, Republic of

Correlation Between Estimated Glomerular Filtration Rate(eGFR) and Vascular Inflammation Measured by Positron Emission Tomography (PET) With 18F-fluoro-deoxyglucose (FDG)

Completed

Conditions: Atherosclerosis

Interventions: Radiation: 18FDG-PET

First Posted Date: 2015-03-20

Last Posted Date: 2016-09-08

Lead Sponsor: Korea University

Target Recruit Count: 360

Registration Number: NCT02394743

Locations: 🇰🇷
Department of Internal Medicine, Korea University College of Medicine, Seoul, VD, Korea, Republic of

Serum ANGPTL3, ANGPTL8 and Glypican 4 Concentrations in Relation to the Development of Obesity in Korean Children

Completed

Conditions: Obesity

First Posted Date: 2015-03-17

Last Posted Date: 2016-03-01

Lead Sponsor: Korea University

Target Recruit Count: 457

Registration Number: NCT02389556

Locations: 🇰🇷
Department of Internal Medicine, Korea University College of Medicine, Seoul, VD, Korea, Republic of

Investigation on Appropriate Duration of Dabigatran Use After Catheter Ablation for Paroxysmal Atrial Fibrillation in Patients With Low Thromboembolic Risk

Phase 3

Conditions: Atrial Fibrillation
Thromboembolism

Interventions: Drug: dabigatran
Drug: placebo

First Posted Date: 2014-12-10

Last Posted Date: 2014-12-10

Lead Sponsor: Korea University

Target Recruit Count: 464

Registration Number: NCT02313584

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy